Company: INDP
Filing Date: 2025-09-02
Form Type: S-1
Source: 0001493152-25-012531
Chunk: 33

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-09-02
Form: S-1
Chunk 33
---
 that we enter into a securities purchase agreement to sell the securities offered hereby. We expect to close the offering on or before , 2025. We will deliver all securities to be issued in connection with this offering delivery versus payment/receipt versus payment upon receipt of investor funds received by us. Accordingly, neither we nor the Placement Agent have made any arrangements to place investor funds in an escrow account or trust account since the Placement Agent will not receive investor funds in connection with the sale of the securities offered hereunder.

We expect to deliver the shares of common stock, pre-funded warrants and common warrants being offered pursuant to this prospectus on or about , 2025.

Fees and Expenses

The following table shows the per share and accompanying common warrants and per pre-funded warrant and accompanying common warrants and total placement agent fees we will pay in connection with the sale of the securities in this offering.

|                                 |     | Per Share and       
 Accompanying Common 
 Warrants            |     | Per                             
 Pre-Funded                      
 Warrant and Accompanying Common 
 Warrants                        |     | Total |
| Combined public offering price  |     |                     |     |                                 |     |       |
| Placement agent fees            |     |                     |     |                                 |     |       |
| Proceeds to us, before expenses |     |                     |     |                                 |     |       |

We have agreed to pay the Placement Agent a cash fee equal to 7.0% of the aggregate gross proceeds raised in this offering and a management fee equal to 1.0% of the gross proceeds raised in this offering. In addition, we have agreed to reimburse the Placement Agent $50,000 for its non-accountable expenses and up to $100,000 for legal fees and out-of-pocket expenses and for its clearing expenses in the amount of up to $15,950. We estimate the total offering expenses of this offering that will be payable by us, excluding the Placement Agent fees and expenses, will be approximately $100,000.

Placement Agent Warrants

In addition, we have agreed to issue to the Placement Agent, or its designees, the Placement Agent Warrants to purchase up to 46,875 shares (which represents 6.0% of the aggregate number of shares issued in this offering and issuable upon the exercise of the pre-funded warrants issued in this offering) with an exercise price of $ per share (representing 125% of the assumed combined public offering price per share and accompanying common warrants). The Placement Agent